SE9801695D0 - Inhibition of p53 function by a p53-derived peptide - Google Patents

Inhibition of p53 function by a p53-derived peptide

Info

Publication number
SE9801695D0
SE9801695D0 SE9801695A SE9801695A SE9801695D0 SE 9801695 D0 SE9801695 D0 SE 9801695D0 SE 9801695 A SE9801695 A SE 9801695A SE 9801695 A SE9801695 A SE 9801695A SE 9801695 D0 SE9801695 D0 SE 9801695D0
Authority
SE
Sweden
Prior art keywords
function
substance
inhibition
dna binding
derived peptide
Prior art date
Application number
SE9801695A
Other languages
English (en)
Inventor
Klas Wiman
Galina Selivanova
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE9801695A priority Critical patent/SE9801695D0/sv
Publication of SE9801695D0 publication Critical patent/SE9801695D0/sv
Priority to AU45394/99A priority patent/AU4539499A/en
Priority to PCT/SE1999/000807 priority patent/WO1999058566A1/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9801695A 1998-05-14 1998-05-14 Inhibition of p53 function by a p53-derived peptide SE9801695D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9801695A SE9801695D0 (sv) 1998-05-14 1998-05-14 Inhibition of p53 function by a p53-derived peptide
AU45394/99A AU4539499A (en) 1998-05-14 1999-05-12 Inhibition of p53 function by a p53-derived substance
PCT/SE1999/000807 WO1999058566A1 (en) 1998-05-14 1999-05-12 INHIBITION OF p53 FUNCTION BY A p53-DERIVED SUBSTANCE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801695A SE9801695D0 (sv) 1998-05-14 1998-05-14 Inhibition of p53 function by a p53-derived peptide

Publications (1)

Publication Number Publication Date
SE9801695D0 true SE9801695D0 (sv) 1998-05-14

Family

ID=20411312

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801695A SE9801695D0 (sv) 1998-05-14 1998-05-14 Inhibition of p53 function by a p53-derived peptide

Country Status (3)

Country Link
AU (1) AU4539499A (sv)
SE (1) SE9801695D0 (sv)
WO (1) WO1999058566A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1414846A2 (en) * 2001-08-10 2004-05-06 Medical Research Council Molecule

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2136624A1 (en) * 1992-05-26 1993-12-09 Cornelis J. M. Melief Peptides of human p53 protein for use in human t cell response inducing compositions, and human p53 protein-specific cytotoxic t-lymphocytes
US5659024A (en) * 1994-01-14 1997-08-19 The Burnham Institute Promotors that regulate the expression of genes involved in cell death
AU4394697A (en) * 1996-08-13 1998-03-06 Trustees Of Princeton University, The P53 mutant
CA2183900A1 (en) * 1996-08-22 1998-02-23 Rick E. Preddie Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans

Also Published As

Publication number Publication date
WO1999058566A1 (en) 1999-11-18
AU4539499A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE69821520D1 (de) Verwendung von alkylierten iminozuckern zur behandlung von multipler medikamentenresistenz
DE69939820D1 (de) Internalisierende erbb2 antikörper
DE69904587D1 (de) Sicherheitselement zur verhinderung der fälschung von wertpapieren
PT1028125E (pt) Compostos dipeptidos que tem actividade fungicida e sua utilizacao agronomica
DE69802815D1 (de) Durch galactosidase modifiziertes submucosales gewebe
BR0111298A (pt) Moduladores seletivos dos receptores de andrógenos e métodos para identificação, projeto e uso dos mesmos
DE69835158D1 (de) Zugriffpunkt zur dienstverwaltung
DE69841877D1 (de) Biosensorische Elektrode
DE69909029D1 (de) Kosmetisches oder dermopharmazeutisches Pflaster
WO2000031124A3 (en) Peptides that modulate the interaction of b class ephrins and pdz domains
DE69624699D1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
DE69725144D1 (de) Banknotenechtheitsprüfer
DE69804659D1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE59911879D1 (de) Verwendung von biogenen estrogensulfamaten zur hormonsubstitutionstherapie
DE69834206D1 (de) Inadon und tetralon verbindungen zur hemmung der zellproliferation
FR2774599B1 (fr) Cataplasme
SE9801695D0 (sv) Inhibition of p53 function by a p53-derived peptide
DE69907022D1 (de) Tablettenspender
PT922703E (pt) Benzocicloalcenos substituidos e sua utilizacao como substancias com efeito analgesico
TR199800847A3 (tr) Bir anjiyotensin dönüstürücü enzim inhibitörünün sabit doz bilesimi.
ATA51396A (de) Sicherheitsbindung für snowbord
WO2001051922A3 (en) Identification of peripheral benzodiazepine receptor binding agents
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.